Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity
Drug Development Research · 2026-04 · 87 (2)
DOI: 10.1002/ddr.70261 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Development Research, online erschienen am 15.03.2026. Verfasst von Ebru Koçak Aslan und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Calcium Channel Blockers, Amides, Quinolines. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Hacettepe University Scientific Research Projects Coordination Unit, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
Hexahydroquinoline (HHQ) is a widely recognized scaffold that has garnered considerable attention owing to its diverse pharmacological properties. The structure of HHQ includes a 1,4‐dihydropyridine (DHP) ring, which serves as the pharmacophore for the predominant class of drugs known as calcium channel blockers. DHPs are frequently utilized in the management of cardiovascular diseases and also show potential for pain management. Since all DHPs on the market possess ester functionality, we aimed to employ bioisosteric replacement to observe if their amide‐containing counterparts would still block calcium channels. Therefore, we synthesized new HHQs with ester or amide functionality ( EM1 ‐ EM15 ) and investigated their effects on L‐(Ca v 1.2) and T‐(Ca v 3.2)‐type calcium channels using the whole‐cell patch clamp technique. Although the amide derivatives were somewhat less effective than their ester counterparts, they still blocked calcium channels to a significant degree. Retesting EM4 enantiomers on two types of calcium channels demonstrated that the ( R )‐isomer was more responsible for the blocking activity in both cases. Molecular docking and molecular dynamics simulations demonstrated that ( R )‐EM4 and ( R )‐EM6 adopt binding modes in Ca v 1.2 similar to amlodipine, while showing favorable stability. Docking studies in Ca v 3.2 suggested that EM compounds bind within the Ⅲ‐Ⅳ fenestration, a reported non‐selective DHP binding site. Furthermore, amide derivatives were found to be more metabolically stable based on the in vitro experiments conducted on rat microsomes. Overall, our study reveals HHQ with an amide group as a promising new scaffold for developing future calcium channel blockers for treating cardiovascular and pain conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
- Molecular Design Group, Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany.
- Department of Clinical Neurosciences, Hotchkiss Brain Institute and Alberta Children's Hospital Research Institute, University of Calgary, Calgary, Alberta, Canada.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Acıbadem University, Istanbul, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Başkent University, Bağlıca, Turkey.
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bahçeşehir University, Istanbul, Turkey.
ORCID-Profile: Ebru Koçak Aslan, Göknil Pelin Coşkun, Ayşe Karagüzel, Onur Şahin, Daniel W Armstrong, Gerhard Wolber, Miyase Gözde Gündüz
Förderung
- Hacettepe University Scientific Research Projects Coordination Unit
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Koçak Aslan, E., Lam, K., Huang, S., Coşkun, G. P., Karagüzel, A., Denzinger, K., Birgül, K., Ülgen, M., Nafie, J. W., Şahin, O., Armstrong, D. W., Zamponi, G. W., Wolber, G., & Gündüz, M. G. (2026). Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity. Drug Development Research, 87(2). https://doi.org/10.1002/ddr.70261
Vancouver
Koçak Aslan E, Lam K, Huang S, Coşkun GP, Karagüzel A, Denzinger K, et al. Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity. Drug Development Research. 2026;87(2). doi:10.1002/ddr.70261
BibTeX
@article{KoakAslan2026,
author = {Koçak Aslan, Ebru and Lam, Kevin and Huang, Sun and Coşkun, Göknil Pelin and Karagüzel, Ayşe and Denzinger, Katrin and Birgül, Kaan and Ülgen, Mert and Nafie, Jordan W and Şahin, Onur and Armstrong, Daniel W and Zamponi, Gerald W and Wolber, Gerhard and Gündüz, Miyase Gözde},
title = {Hexahydroquinoline Featuring Amide Functionality: A Promising Scaffold With Calcium Channel Blocking Activity},
journal = {Drug Development Research},
year = {2026},
volume = {87},
number = {2},
doi = {10.1002/ddr.70261}
}
EUVIMED